Table III.
Phenotypic correlations between different offspring outcomes across treatments.
Natural mating |
IV-ET-2cell |
IV-ET-BL |
IVF-ET-2cell |
IVF-ET-BL |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Male (n = 8) | Female (n = 8) | Male (n = 6–8) | Female (n = 7–8) | Male (n = 6–8) | Female (n = 6–7) | Male (n = 8–9) | Female (n = 7–9) | Male (n = 7–9) | Female (n = 7–9) | |
Cardiovascular phenotype | ||||||||||
SBP wk21 − Lung ACE | −0.190 | 0.415 | 0.556 | 0.370 | 0.184 | 0.130 | −0.026 | 0.223 | 0.902* | −0.119 |
SBP LIFE − Lung ACE | 0.118 | 0.107 | 0.415 | 0.353 | 0.693$ | 0.328 | 0.101 | 0.195 | 0.714* | −0.177 |
G:I and body weight | ||||||||||
G:I ratio − BW3 | −0.305 | −0.351 | −0.211 | −0.566 | −0.403 | 0.080 | −0.224 | 0.160 | −0.676$ | −0.268 |
G:I ratio − BW9 | 0.111 | 0.169 | −0.621 | −0.649 | 0.936* | 0.789$ | −0.806* | −0.073 | −0.664 | −0.013 |
G:I ratio − BW15 | 0.128 | −0.303 | −0.761$ | −0.735$ | −0.904* | 0.749$ | −0.807* | −0.309 | −0.700$ | −0.053 |
G:I ratio − BW21 | 0.287 | −0.184 | −0.848* | −0.710$ | −0.871* | 0.664 | −0.812* | 0.008 | −0.748$ | 0.122 |
G:I ratio − BW27 | 0.001 | −0.448 | −0.832* | −0.883* | −0.768$ | 0.910* | −0.935* | −0.026 | −0.806* | −0.741$ |
G:I ratio − FG | −0.523 | −0.183 | −0.040 | −0.431 | −0.651 | 0.471 | −0.640$ | −0.090 | 0.437 | 0.198 |
G:I ratio − GTT 15 min | −0.010 | −0.021 | −0.082 | −0.282 | −0.383 | 0.679 | −0.806* | 0.137 | −0.767* | 0.234 |
G:I ratio − GTT 120 min | 0.298 | −0.350 | −0.753$ | −0.547 | −0.432 | 0.927* | −0.648$ | 0.043 | −0.707$ | −0.201 |
Insulin – AUC | 0.023 | −0.111 | −0.013 | 0.208 | 0.252 | −0.912* | 0.860* | −0.315 | 0.659 | 0.420 |
G:I ratio − AUC | −0.195 | −0.107 | −0.263 | −0.371 | −0.540 | 0.960* | −0.862* | 0.116 | −0.819* | −0.530 |
SBP LIFE, average (SBP9, SBP15 and SBP21); ACE, angiotensin-converting enzyme; G:I G:I ratio, Serum glucose: Serum insulin ratio; BW, body weight as specific week; AUC, area under the curve for GTT test; Insulin, Serum insulin; FG, fasting glucose.
P < 0.1;
P < 0.05.